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1. Introduction 
It was shown in preceding studies that trace 
amounts of a cytoplasmic metabolic factor (CMF) 
prevented certain deleterious effects of uncouplers 
on isolated mitochondria [l-6] . The possibility was 
considered that CMF may be a naturally occurring 
cytoplasmic stabilizing agent of mitochondrial bio- 
energetic functions [7]. Since demonstration of the 
effect of CMF on mitochondria required artificial 
uncouplers, or potentially toxic cellular metabolites 
(e.g. oleic acid or bilirubin, cf. [7]), the apparent 
cellular role of CMF seemed to be confined to pro- 
tection against mitochondrial damage. More recent 
work revealed that artificial uncouplers could be 
replaced by Ca2+ in concentrations found in the 
cytosol [8]. Since, in the presence of Ca2+, energy 
coupled cation movements were influenced by CMF 
in the absence of any artificial uncoupler, the Ca2’- 
CMF antagonism assumed cell physiological interest. 
The present report is concerned with the time 
course of Ca2+-induced cation movements. As an 
extention of a previous observation [cf. 81, it was 
confirmed that oligomycin inhibits Ca2+-induced 
cation flux, and this effect of oligomycin is similar to 
that of CMF. 
Abbreviation 
CMF = cytoplasm&z metabolic factor 
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2. Experimental procedures 
Because the published methods for the isolation of 
partially purified CMF [2-41 underwent some modi- 
fication, a brief description of a procedure for partial 
purification of CMF used in these experiments will be 
given. Pig liver (1.8 kg) kept in cracked ice during 
transportation from the slaughterhouse was homo- 
genized in 300 g portions for 45 set (at 4”) in a 
Sorvall Omni-Mixer with 1.8 litre distilled H,O and 
crude sediments were removed by centrifugation at 
16,300 g for 1 hr at 4”. The bulk of protein of the 
supernatant fluid was removed by heat coagulation 
(submersion of 70 ml batches in Erlenmeyer flasks for 
2.5 to 3 min in boiling H,O baths), and the volume of 
the supernatant of the heat-treated extract obtained 
by a second centrifugation (40 min at 34,800 g at 4”) 
was reduced to 250 ml by freeze-drying. This concen- 
trated extract, which contained all CMF present in 
the liver, was fractionated on a large Sephadex G-25 
column. equilibrated and developed with H,O at 4”. 
The size of the column was 9.5 X 50 cm, bed volume = 
3.5 1, void volume = 1.2 1. The flow rate was 10 ml/min 
and 15 ml fractions were collected. Analysis for CMF 
activity was performed by the metabolic assay [cf. 31. 
After the void volume, residual proteins were eluted 
in 500 to 600 ml. This was followed by the CMF 
containing peak (800 to 1000 ml) and finally by a 
yellow colored peak (500 to 600 ml) which had no 
activity. The volume of the CMF containing eluate 
was reduced to 100 ml by freeze-drying. This extract 
was passed through a Chelex (BioRad) column (3.5 X 
4.5 cm in Na+ form, containing 35 g resin, equilibrated 
at neutral pH), then through a Dowex-1 -bicarbonate 
81 
Volume 18, number 1 FEBS LETTERS October 1971 
column (3 X 1 cm, 6 g resin), both developed with 
H20. The eluate (about 100 ml) was freeze-dried 
until a solid material was formed (about 3 g). This 
material contained 70 to 80% of CMF present in the 
original extract, comprising on a weight basis a 600- 
fold purification, although this may be greater because 
the material was hygroscopic. It contained no Ca 2÷, 
Mg z÷ or nucleotides, and no detectable rnitochondrial 
subunits, but was contaminated with variable quanti- 
ties of ninhydrin reactive and carbohydrate material. 
Based on further purification, when these contamin- 
ants were removed*, the purity of this extract with 
respect o the active component of CMF was estimated 
to be 1 to 3%. When activity was related to total 
organic matter, (dichromate reducing material with 
glucose as primary standard, cf. [9] ), maximal CMF 
activity was obtained at 0.4 to 0.6 mg/ml concentra- 
tions. Partially purified CMF in this form is stable 
for several months in the frozen state. Various char- 
acteristics of the active small molecular (less than 
1000 daltons) component have been reported [cf. 5]. 
Isolation of rat liver mitochondria was carried out 
by the Tr is-sucrose-mannitol -BSA procedure [cf. 
10]. The method of determination f cation flux, 
based orr atomic absorption analyses of cations both 
in mitochondria and in the suspending medium at 
various time intervals, was the same as reported earlier 
[3, 5, 81. 
3. Results 
In the experiments shown (fig. 1), rat liver mito- 
chondria were incubated in sucrose-Tris medium at 
30 ° and cation movements determined at 2 to 3 rain 
intervals. In the absence of externally added Ca 2+, 
only traces of Mg 2÷ and Ca 2÷ were ejected into the 
suspending medium. There was also a steady, relatively 
slow outward flux of K ÷. In the presence of externally 
added Ca 2÷ (60 or 37 nmoles Ca2+/mg mitochondrial 
protein), almost all Ca 2÷ was rapidly taken up. For a 
period of 2 to 3 rain, only a small increase of Mg 2÷ and 
K ÷ efflux was detectable. After this period of latency, 
Mg 2÷ and K ÷ efflux greatly accelerated, while Ca 2÷ was 
still retained for an additional 2 -3  min. When virtually 
all mitochondrial Mg z÷ and K ÷ were ejected, mito- 
* In preparation: to be submitted to Biochemistry. 
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Fig. 1. Liver mitochondria (2.8 mg/ml in Iand 2.4 mg in II) 
were incubated at30 ° in a Dubnoff shaker in 50 ml beakers. 
The volume of incubation mixture was 6 ml, consisting of 
250 mM sucrose + 30 mM Tris-HC1 (pH 7.4). Cation content 
of mitochondria and the suspending medium were determined 
simultaneously at 2 to 3 min intervals after rapid centrifugal 
sedimentation f mitochondria at 0 to 4 ° [cf. 3]. Time is 
shown on the abscissa. Mitochondrial Mg 2+ and K ÷ release is
calculated as #moles of cations extruded from 1 g mitochon- 
drial protein as recorded on the ordinate (a and b). The 
movement of Ca 2+ is calculated in the same manner by ex- 
pressing the variation of mitochondrial Ca 2~ content. Original 
Ca 2+ content of mitochondria was 10 t~moles Ca2+/g mito- 
chondrial protein. In Ic and IIc, Ca 2~ uptake is shown by the 
increase in mitochondrial Ca 2+ above and Ca 2+ loss by the 
decrease below this value (ordinate). The amounts of exter- 
nally added Ca 2+ are shown on the top of the figure;CMF = 
0.46 mg organic matter/ml; oligomycin = 2.8 gg/mg mito- 
chondrial protein. 
chondrial Ca 2÷ was also released and even some oi~the 
originally bound Ca 2÷ appeared in the suspending 
medium. Cation ejection was prevented, Ca 2÷ uptake 
increased, and Ca 2÷ retention sustained when CMF or 
oligomycin were present during incubation, or were 
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added within 3 min after the exposure of mitochondria 
to Ca’+. This relatively short period of reversibility of 
the effects of Ca*+ by CMF may be of cellular physio- 
logical importance, since it allows short cycles of 
oscillations of energy linked processes of the inner 
membrane [cf. 71 . Endogenous respiration is essential 
for Ca*+-induced cation flux; rotenone (lo-’ M) 
prevented Mg*+ and K+ efflux, and inhibited the effect 
of CMF. Oligomycin did not inhibit endogenous respir- 
ation. 
4. Discussion 
Similarity in action between the cellular substance 
CMF and oligomycin suggests that the mitochondrial 
site for oligomycin is a part of a cellular regulatory 
system which, under physiological conditions, 
responds to CMF. It is known [I l] that mitochondrial 
ATP synthesis is inhibited during energy coupled Ca*+ 
uptake, presumably because metabolic energy is used 
for Ca2+ translocation in preference to the phosphoryl- 
ation of ADP. Our experimental conditions correspond 
to this energetic pattern during the first 3 to 5 min 
after exposure of mitochondria to Ca*+. Thereafter, 
energy coupling to cation retention fails unless CMF 
or oligomycin is added, indicating that both agents 
stabilize a component of the energy transfer system 
which can couple respiration to cation retention. It is 
known from the work of Lardy et al. [ 12-151, that 
oligomycin blocks energy transfer reactions leading to 
ATP synthesis, but not to other processes (e.g. cation 
translocation); in fact, oligomycin was shown to 
promote energy transfer under non-phosphorylating 
conditions [ 16-191. We conclude that the common 
site of CMF and oligomycin is this - as yet unknown 
portion of the energy transducing system, preceding 
ATP synthesis. Previous experiments [3-81 indicated 
that this site may be a ligand system of Mg*+, thus 
- X-Mg2+ could represent a non-phosphorylated 
energized intermediate of energy transfer. The signifi- 
cant difference between CMF and oligomycin is that 
the former sustains oxidative phosphorylation [cf. 71, 
while the latter inhibits it. This difference indicates 
that the toxic antibiotic simulates only one mode of 
action of CMF. The common site of CMF and oligo- 
mycin is not shared by aurovertin [cf. 81. 
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